...
首页> 外文期刊>The Journal of Nuclear Medicine >Evaluation of In Vivo P-Glycoprotein Function at the Blood-Brain Barrier Among MDR1 Gene Polymorphisms by Using 11C-Verapamil
【24h】

Evaluation of In Vivo P-Glycoprotein Function at the Blood-Brain Barrier Among MDR1 Gene Polymorphisms by Using 11C-Verapamil

机译:使用11 C-维拉帕米评估MDR1基因多态性之间的血脑屏障的体内P糖蛋白功能。

获取原文
           

摘要

id="p-1">P-glycoprotein (P-gp) is a membrane protein that functions as an adenosine triphosphate-dependent efflux pump for xenobiotics at the blood-brain barrier (BBB). Polymorphisms of MDR1 gene have been reported to be associated with the expression level of P-gp. 11C-Verapamil is considered to be one of the suitable radioligands for evaluating P-gp functions. However, the metabolites of verapamil might complicate the quantitative analysis because of their possible brain penetration. In the present study, we investigated the P-gp functional differences at the BBB between the haplotypes (1236TT, 2677TT, 3435TT vs. 1236CC, 2677GG, 3435CC) of the MDR1 gene with different quantitative analyses of 11C-verapamil. >Methods: Thirty-three healthy male volunteers were enrolled in this study after identification of the haplotypes of the MDR1 gene. Brain PET scans with 11C-verapamil were performed for 16 min. Integration plot analysis, which yields brain uptake clearance, was performed with the first 3-min data. Integration plot analysis was then compared with several other quantitative analyses with 16-min data (1-input, 1-tissue compartment model, and the area under the curve ratio (AUCratio) between brain and plasma). >Results: In the integration plot, there was no difference in the absolute values of brain uptake clearance (CLuptake) between the haplotypes; CLuptake of 11C-verapamil for the haplotypes (1236TT, 2677TT, 3435TT vs. 1236CC, 2677GG, 3435CC) were 0.053 ?± 0.011 and 0.051 ?± 0.011 mL/g/min, respectively. CLuptake of 11C-verapamil in the integration plot was significantly correlated with K1 and DV(K1/k2) (DV is distribution volume; K1 and k2 are plasma and tissue rate constants) in the 1-input, 1-tissue compartment model and the AUCratio. >Conclusion: On the basis of the several quantitative analyses of 11C-verapamil, the assumption that the function of P-gp at the BBB is different between the haplotypes (3 single nucleotide polymorphisms: C1236T, G2677T, and C3435T) of MDR1 gene was not supported.
机译:id =“ p-1”> P-糖蛋白(P-gp)是一种膜蛋白,在血脑屏障(BBB)上用作异生物素的三磷酸腺苷依赖性外排泵。据报道,MDR1基因的多态性与P-gp的表达水平有关。 11 C-维拉帕米被认为是评估P-gp功能的合适放射性配体之一。但是,维拉帕米的代谢物可能会渗透到大脑,因此可能会使定量分析复杂化。在本研究中,我们通过对 11 进行了定量分析,研究了MDR1基因的单倍型(1236TT,2677TT,3435TT与1236CC,2677GG,3435CC)之间在BBB处的P-gp功能差异。 C-维拉帕米。 >方法:在鉴定了MDR1基因的单倍型后,本研究纳入了33名健康男性志愿者。用 11 C-维拉帕米进行脑部PET扫描16分钟。使用前3分钟的数据进行积分图分析,产生大脑摄取清除率。然后将积分图分析与其他16分钟数据定量分析(1输入,1组织隔室模型,以及脑与血浆之间曲线比率下的面积(AUC <比率> ))进行比较。 >结果:在积分图中,单倍型之间的脑摄取清除率的绝对值(CL 摄取)没有差异;单倍型(1236TT,2677TT,3435TT与1236CC,2677GG,3435CC)的 11 C-维拉帕米的CL 摄取分别为0.053?±0.011和0.051?±0.011 mL /克/分钟。积分图中 11 C-维拉帕米的CL 摄取与K1和DV(K1 / k2)显着相关(DV为分布体积; K1和k2为血浆和组织1输入1组织隔室模型和AUC ratio 。 >结论:在对 11 C-维拉帕米的定量分析的基础上,单倍型之间P-gp在BBB上的功能不同的假设(3个单一不支持MDR1基因的核苷酸多态性:C1236T,G2677T和C3435T)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号